Amedica was awarded U.S. Patent No. 9,399,309 for threading sinterable materials, covering methods used for spinal fusion or other biomedical implants.
Histogenics closed its previously-announced US $30.0MM private placement. Funds will support development of NeoCart® novel cartilage repair therapy, including completion of the ongoing Phase III clinical trial.